½ÃÀ庸°í¼­
»óǰÄÚµå
1612836

¼Ò °áÇÙ Áø´Ü ½ÃÀå : ¼¼°è »ê¾÷ ºÐ¼®, ±Ô¸ð, Á¡À¯À², ¼ºÀå, µ¿Çâ, ¿¹Ãø(2024-2031³â)

Bovine Tuberculosis Diagnosis Market: Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2024-2031

¹ßÇàÀÏ: | ¸®¼­Ä¡»ç: Persistence Market Research | ÆäÀÌÁö Á¤º¸: ¿µ¹® 173 Pages | ¹è¼Û¾È³» : 2-5ÀÏ (¿µ¾÷ÀÏ ±âÁØ)

    
    
    




¡Ø º» »óǰÀº ¿µ¹® ÀÚ·á·Î Çѱ۰ú ¿µ¹® ¸ñÂ÷¿¡ ºÒÀÏÄ¡ÇÏ´Â ³»¿ëÀÌ ÀÖÀ» °æ¿ì ¿µ¹®À» ¿ì¼±ÇÕ´Ï´Ù. Á¤È®ÇÑ °ËÅ並 À§ÇØ ¿µ¹® ¸ñÂ÷¸¦ Âü°íÇØÁֽñ⠹ٶø´Ï´Ù.

ÁÖ¿ä ÀλçÀÌÆ®

  • ¼Ò °áÇÙ Áø´Ü ½ÃÀå ±Ô¸ð : 7¾ï 6,860¸¸ ´Þ·¯(2024³â)
  • ¿¹»ó ½ÃÀå ±Ô¸ð : 10¾ï 5,320¸¸ ´Þ·¯(2031³â)
  • ¼¼°è ½ÃÀå ¼ºÀå·ü : 4.4%(2024-2031³â CAGR)

¼Ò °áÇÙ Áø´Ü ½ÃÀå - º¸°í¼­ ¹üÀ§

¼Ò °áÇÙ Áø´Ü ½ÃÀåÀº °¡Ãà, ƯÈ÷ ¼ÒÀÇ °áÇÙÀ» °ËÃâÇϰí Áø´ÜÇÏ´Â µ¥ »ç¿ëµÇ´Â ±â¼ú ¹× ¹æ¹ýÀ» ÀǹÌÇÕ´Ï´Ù. ÀÌ Áúº´Àº °¡ÃàÀÇ °Ç°­¿¡ ¿µÇâÀ» ¹ÌÄ¡°í ¹«¿ª Á¦ÇѰú ¼öÀÇÇÐÀû Ä¡·á ºñ¿ëÀ¸·Î ÀÎÇÑ ¸·´ëÇÑ °æÁ¦Àû ¼Õ½ÇÀ» ÃÊ·¡Çϱ⠶§¹®¿¡ ³ó¾÷ ºÎ¹®ÀÇ Å« °ü½É»çÀÔ´Ï´Ù. Àμö°øÅëÀü¿°º´¿¡ ´ëÇÑ ¿ì·ÁÀÇ Áõ°¡, Á¤È®ÇÏ°í ½Å¼ÓÇÑ Áø´ÜÀÇ Çʿ伺, ¼Ò °áÇÙ ¹ßº´ÀÇ °æÁ¦Àû ¿µÇâ¿¡ ´ëÇÑ ÀνÄÀÇ Áõ°¡°¡ ½ÃÀåÀ» ÁÖµµÇϰí ÀÖ½À´Ï´Ù.

½ÃÀå ¼ºÀå ÃËÁø¿äÀÎ

¼¼°è ¼Ò °áÇÙ Áø´Ü ½ÃÀåÀÇ ¼ºÀå¿¡´Â ¿©·¯ °¡Áö ¿äÀÎÀÌ ÀÛ¿ëÇϰí ÀÖ½À´Ï´Ù. ¼Ò °áÇÙ À¯º´·ü Áõ°¡, µ¿¹° ÀÇ·á¿¡ ´ëÇÑ ÅõÀÚ Áõ°¡, PCR °Ë»ç, ¸é¿ª Áø´Ü, ¿µ»ó ±â¼ú µî ÷´Ü Áø´Ü ±â¼ú µµÀÔ µîÀÌ ±× ¿¹ÀÔ´Ï´Ù. ¶ÇÇÑ, ¹é½Å Á¢Á¾ ÇÁ·Î±×·¥°ú ¾ö°ÝÇÑ ±ÔÁ¦¸¦ ÅëÇØ ¼Ò °áÇÙ¿¡ ´ëÀÀÇϱâ À§ÇÑ Á¤ºÎÀÇ ³ë·ÂÀÌ ½ÃÀå ¼ºÀåÀ» µÞ¹ÞħÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. °íǰÁú À¯Á¦Ç° ¹× À°·ù Á¦Ç°¿¡ ´ëÇÑ ¼ö¿ä Áõ°¡¿Í Áúº´ ¾ø´Â °¡Ãà¿¡ ´ëÇÑ ¼ö¿äµµ ½ÃÀåÀ» °ßÀÎÇϰí ÀÖ½À´Ï´Ù.

½ÃÀå ¾ïÁ¦¿äÀÎ

½ÃÀå Àü¸ÁÀº ¹àÁö¸¸, ¼Ò °áÇÙ Áø´Ü ½ÃÀåÀº ³ôÀº Áø´Ü ºñ¿ë°ú °¡Ãà °áÇÙ °Ë»çÀÇ º¹À⼺À̶ó´Â µµÀü¿¡ Á÷¸éÇØ ÀÖ½À´Ï´Ù. ¶ÇÇÑ ÀϺΠÁö¿ª, ƯÈ÷ °³¹ßµµ»ó±¹¿¡¼­´Â Áø´Ü ÇÁ·ÎÅäÄÝÀÌ Ç¥ÁØÈ­µÇ¾î ÀÖÁö ¾ÊÀº °Íµµ ¹ßÀüÀ» ÀúÇØÇÏ´Â ¿äÀÎÀ¸·Î ÀÛ¿ëÇÒ ¼ö ÀÖ½À´Ï´Ù. ¶ÇÇÑ, ÀüÅëÀûÀÎ ³ó¾÷ ½Ã½ºÅÛ¿¡¼­ ½Å±â¼ú µµÀÔÀÌ ´Ê¾îÁö°í °¡Ãà Áúº´ °ü¸®¿Í °ü·ÃµÈ ±ÔÁ¦ À庮µµ ½ÃÀå ¼ºÀåÀ» Á¦ÇÑÇÒ ¼ö ÀÖ½À´Ï´Ù.

½ÃÀå ±âȸ

¼Ò °áÇÙ Áø´Ü ½ÃÀåÀº Áø´Ü ±â¼úÀÇ Çõ½Å°ú ½Å¼ÓÇÏ°í ºñ¿ë È¿À²ÀûÀÎ °Ë»ç ¹æ¹ýÀÇ Ã¤Åà Áõ°¡·Î ÀÎÇØ Å« ±âȸ¸¦ âÃâÇϰí ÀÖ½À´Ï´Ù. ÇöÀå Áø´Ü ¼Ö·ç¼Ç°ú ¸ð¹ÙÀÏ Áø´Ü Ç÷§ÆûÀÇ °³¹ßÀº ƯÈ÷ ³óÃÌ ¹× ¿Üµý Áö¿ª¿¡¼­ ¼Ò °áÇÙ Áø´ÜÀÇ Á¢±Ù¼º°ú È¿À²¼ºÀ» Çâ»ó½Ãų °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. ¶ÇÇÑ, ¼Ò °áÇÙ°ú °ü·ÃµÈ °æÁ¦Àû, °øÁߺ¸°ÇÀû À§Çè¿¡ ´ëÇÑ ÀνÄÀÌ ³ô¾ÆÁü¿¡ µû¶ó ÀÌ ºÐ¾ßÀÇ ¿¬±¸°³¹ßÀ» Áö¿øÇϱâ À§ÇÑ ÀÚ±Ý Áö¿ø°ú ¹Î°ü ÆÄÆ®³Ê½ÊÀÌ Áõ°¡ÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.

ÀÌ º¸°í¼­´Â ¼¼°è ¼Ò °áÇÙ Áø´Ü ½ÃÀåÀ» Á¶»ç ºÐ¼®ÇÏ¿© ½ÃÀå ¿ªÇÐ ºÐ¼®, ÃËÁø¿äÀÎ, µ¿Çâ, ±âȸ, °úÁ¦ µî ½ÃÀå ¿ªÇÐ ºÐ¼®°ú ½ÃÀå »óȲ¿¡ ´ëÇÑ ÀλçÀÌÆ®¸¦ Á¦°øÇÕ´Ï´Ù.

¸ñÂ÷

Á¦1Àå ÁÖ¿ä ¿ä¾à

Á¦2Àå ½ÃÀå °³¿ä

  • ½ÃÀå ¹üÀ§¿Í Á¤ÀÇ
  • ½ÃÀå ¿ªÇÐ
    • ¼ºÀå ÃËÁø¿äÀÎ
    • ¼ºÀå ¾ïÁ¦¿äÀÎ
    • ±âȸ
    • °úÁ¦
    • ÁÖ¿ä µ¿Çâ
  • °Å½Ã°æÁ¦ ¿äÀÎ
    • ¼¼°èÀÇ ºÎ¹® Àü¸Á
    • ¼¼°èÀÇ GDP ¼ºÀå Àü¸Á
    • ¼¼°èÀÇ ÀÇ·á ÁöÃâ Àü¸Á
  • COVID-19ÀÇ ¿µÇ⠺м®
  • ¿¹Ãø¿äÀÎ - °ü·Ã¼º°ú ¿µÇâ

Á¦3Àå ºÎ°¡°¡Ä¡ ÀλçÀÌÆ®

  • °Ë»ç À¯Çü ä¿ë ºÐ¼®
  • ±ÔÁ¦ »óȲ
  • ¹ë·ùüÀÎ ºÐ¼®
    • À¯Åë ä³Î/¸¶ÄÏÇ÷¹À̽º ¸®½ºÆ®
    • ÃÖÁ¾ ¿ëµµ(»ê¾÷) ¸®½ºÆ®
  • ÁÖ¿ä °Å·¡¿Í ÇÕº´
  • PESTLE ºÐ¼®
  • Porter's Five Forces ºÐ¼®

Á¦4Àå ¼Ò °áÇÙ Áø´Ü ½ÃÀå Àü¸Á : °ú°Å(2019-2023³â)¿Í ¿¹Ãø(2024-2031³â)

  • ÁÖ¿ä ÇÏÀ̶óÀÌÆ®
    • ½ÃÀå ±Ô¸ð¿Í Àü³âºñ ¼ºÀå
    • Àý´ëÀû ¼öÀÍ ±âȸ
  • ½ÃÀå ±Ô¸ð ºÐ¼®°ú ¿¹Ãø
    • ½ÃÀå ±Ô¸ð ½ÇÀû ºÐ¼®(2019-2023³â)
    • ÇöÀç ½ÃÀå ±Ô¸ð ºÐ¼®°ú ¿¹Ãø(2024-2031³â)
  • ¼Ò °áÇÙ Áø´Ü ½ÃÀå Àü¸Á : °Ë»ç Á¾·ù
    • ½ÃÀå ±Ô¸ð ½ÇÀû ºÐ¼® : °Ë»ç À¯Çüº°(2019-2023³â)
    • ÇöÀç ½ÃÀå ±Ô¸ð ºÐ¼®°ú ¿¹Ãø : °Ë»ç À¯Çüº°(2024-2031³â)
    • ½ÃÀå ¸Å·Â ºÐ¼® : °Ë»ç À¯Çü

Á¦5Àå ¼Ò °áÇÙ Áø´Ü ½ÃÀå Àü¸Á : Áö¿ª

  • ÁÖ¿ä ÇÏÀ̶óÀÌÆ®
  • ½ÃÀå ±Ô¸ð ½ÇÀû ºÐ¼® : Áö¿ªº°(2019-2023³â)
  • ÇöÀç ½ÃÀå ±Ô¸ð ºÐ¼®°ú ¿¹Ãø : Áö¿ªº°(2024-2031³â)
    • ºÏ¹Ì
    • À¯·´
    • µ¿¾Æ½Ã¾Æ
    • ³²¾Æ½Ã¾Æ ¹× ¿À¼¼¾Æ´Ï¾Æ
    • ¶óƾ¾Æ¸Þ¸®Ä«
    • Áßµ¿ ¹× ¾ÆÇÁ¸®Ä«
  • ½ÃÀå ¸Å·Â ºÐ¼® : Áö¿ª

Á¦6Àå ºÏ¹ÌÀÇ ¼Ò °áÇÙ Áø´Ü ½ÃÀå Àü¸Á : °ú°Å(2019-2023³â)¿Í ¿¹Ãø(2024-2031³â)

  • ÁÖ¿ä ÇÏÀ̶óÀÌÆ®
  • ½ÃÀå ±Ô¸ð ½ÇÀû ºÐ¼® : ½ÃÀ庰(2019-2023³â)
    • ±¹°¡º°
    • °Ë»ç À¯Çüº°
  • ÇöÀç ½ÃÀå ±Ô¸ð ºÐ¼®°ú ¿¹Ãø : ±¹°¡º°(2024-2031³â)
    • ¹Ì±¹
    • ij³ª´Ù
  • ÇöÀç ½ÃÀå ±Ô¸ð ºÐ¼®°ú ¿¹Ãø : °Ë»ç À¯Çüº°(2024-2031³â)
    • Ç÷ûÇÐÀû °Ë»ç
    • ºÐÀÚÁø´Ü °Ë»ç
    • ÀüÅëÀûÀÎ °Ë»ç
  • ½ÃÀå ¸Å·Â ºÐ¼®

Á¦7Àå À¯·´ÀÇ ¼Ò °áÇÙ Áø´Ü ½ÃÀå Àü¸Á : °ú°Å(2019-2023³â)¿Í ¿¹Ãø(2024-2031³â)

  • ÁÖ¿ä ÇÏÀ̶óÀÌÆ®
  • ½ÃÀå ±Ô¸ð ½ÇÀû ºÐ¼® : ½ÃÀ庰(2019-2023³â)
    • ±¹°¡º°
    • °Ë»ç À¯Çüº°
  • ÇöÀç ½ÃÀå ±Ô¸ð ºÐ¼®°ú ¿¹Ãø : ±¹°¡º°(2024-2031³â)
    • µ¶ÀÏ
    • ÇÁ¶û½º
    • ¿µ±¹
    • ÀÌÅ»¸®¾Æ
    • ½ºÆäÀÎ
    • ·¯½Ã¾Æ
    • ÅÍŰ
    • ±âŸ À¯·´
  • ÇöÀç ½ÃÀå ±Ô¸ð ºÐ¼®°ú ¿¹Ãø : °Ë»ç À¯Çüº°(2024-2031³â)
    • Ç÷ûÇÐÀû °Ë»ç
    • ºÐÀÚÁø´Ü °Ë»ç
    • ÀüÅëÀûÀÎ °Ë»ç
  • ½ÃÀå ¸Å·Â ºÐ¼®

Á¦8Àå µ¿¾Æ½Ã¾ÆÀÇ ¼Ò °áÇÙ Áø´Ü ½ÃÀå Àü¸Á : °ú°Å(2019-2023³â)¿Í ¿¹Ãø(2024-2031³â)

  • ÁÖ¿ä ÇÏÀ̶óÀÌÆ®
  • ½ÃÀå ±Ô¸ð ½ÇÀû ºÐ¼® : ½ÃÀ庰(2019-2023³â)
    • ±¹°¡º°
    • °Ë»ç À¯Çüº°
  • ÇöÀç ½ÃÀå ±Ô¸ð ºÐ¼®°ú ¿¹Ãø : ±¹°¡º°(2024-2031³â)
    • Áß±¹
    • ÀϺ»
    • Çѱ¹
  • ÇöÀç ½ÃÀå ±Ô¸ð ºÐ¼®°ú ¿¹Ãø : °Ë»ç À¯Çüº°(2024-2031³â)
    • Ç÷ûÇÐÀû °Ë»ç
    • ºÐÀÚÁø´Ü °Ë»ç
    • ÀüÅëÀûÀÎ °Ë»ç
  • ½ÃÀå ¸Å·Â ºÐ¼®

Á¦9Àå ³²¾Æ½Ã¾Æ ¹× ¿À¼¼¾Æ´Ï¾ÆÀÇ ¼Ò °áÇÙ Áø´Ü ½ÃÀå Àü¸Á : °ú°Å(2019-2023³â)¿Í ¿¹Ãø(2024-2031³â)

  • ÁÖ¿ä ÇÏÀ̶óÀÌÆ®
  • ½ÃÀå ±Ô¸ð ½ÇÀû ºÐ¼® : ½ÃÀ庰(2019-2023³â)
    • ±¹°¡º°
    • °Ë»ç À¯Çüº°
  • ÇöÀç ½ÃÀå ±Ô¸ð ºÐ¼®°ú ¿¹Ãø : ±¹°¡º°(2024-2031³â)
    • Àεµ
    • µ¿³²¾Æ½Ã¾Æ
    • È£ÁÖ
    • ±âŸ ³²¾Æ½Ã¾Æ ¹× ¿À¼¼¾Æ´Ï¾Æ
  • ÇöÀç ½ÃÀå ±Ô¸ð ºÐ¼®°ú ¿¹Ãø : °Ë»ç À¯Çüº°(2024-2031³â)
    • Ç÷ûÇÐÀû °Ë»ç
    • ºÐÀÚÁø´Ü °Ë»ç
    • ÀüÅëÀûÀÎ °Ë»ç
  • ½ÃÀå ¸Å·Â ºÐ¼®

Á¦10Àå ¶óÆ¾¾Æ¸Þ¸®Ä«ÀÇ ¼Ò °áÇÙ Áø´Ü ½ÃÀå Àü¸Á : °ú°Å(2019-2023³â)¿Í ¿¹Ãø(2024-2031³â)

  • ÁÖ¿ä ÇÏÀ̶óÀÌÆ®
  • ½ÃÀå ±Ô¸ð ½ÇÀû ºÐ¼® : ½ÃÀ庰(2019-2023³â)
    • ±¹°¡º°
    • °Ë»ç À¯Çüº°
  • ÇöÀç ½ÃÀå ±Ô¸ð ºÐ¼®°ú ¿¹Ãø : ±¹°¡º°(2024-2031³â)
    • ºê¶óÁú
    • ¸ß½ÃÄÚ
    • ±âŸ ¶óƾ¾Æ¸Þ¸®Ä«
  • ÇöÀç ½ÃÀå ±Ô¸ð ºÐ¼®°ú ¿¹Ãø : °Ë»ç À¯Çüº°(2024-2031³â)
    • Ç÷ûÇÐÀû °Ë»ç
    • ºÐÀÚÁø´Ü °Ë»ç
    • ÀüÅëÀûÀÎ °Ë»ç
  • ½ÃÀå ¸Å·Â ºÐ¼®

Á¦11Àå Áßµ¿ ¹× ¾ÆÇÁ¸®Ä«ÀÇ ¼Ò °áÇÙ Áø´Ü ½ÃÀå Àü¸Á : °ú°Å(2019-2023³â)¿Í ¿¹Ãø(2024-2031³â)

  • ÁÖ¿ä ÇÏÀ̶óÀÌÆ®
  • ½ÃÀå ±Ô¸ð ½ÇÀû ºÐ¼® : ½ÃÀ庰(2019-2023³â)
    • ±¹°¡º°
    • °Ë»ç À¯Çüº°
  • ÇöÀç ½ÃÀå ±Ô¸ð ºÐ¼®°ú ¿¹Ãø : ±¹°¡º°(2024-2031³â)
    • GCC ±¹°¡
    • ÀÌÁýÆ®
    • ³²¾ÆÇÁ¸®Ä«°øÈ­±¹
    • ºÏ¾ÆÇÁ¸®Ä«
    • ±âŸ Áßµ¿ ¹× ¾ÆÇÁ¸®Ä«
  • ÇöÀç ½ÃÀå ±Ô¸ð ºÐ¼®°ú ¿¹Ãø : °Ë»ç À¯Çüº°(2024-2031³â)
    • Ç÷ûÇÐÀû °Ë»ç
    • ºÐÀÚÁø´Ü °Ë»ç
    • ÀüÅëÀûÀÎ °Ë»ç
  • ½ÃÀå ¸Å·Â ºÐ¼®

Á¦12Àå °æÀï ±¸µµ

  • ½ÃÀå Á¡À¯À² ºÐ¼®(2023³â)
  • ½ÃÀå ±¸Á¶
    • °æÀï °­µµ ¸Ê : ½ÃÀ庰
    • °æÀï ´ë½Ãº¸µå
  • ±â¾÷ °³¿ä(»ó¼¼ - °³¿ä, À繫, Àü·«, ÃÖ±ÙÀÇ µ¿Çâ)
    • IDEXX Laboratories, Inc.
    • PBD Biotech Ltd
    • Zoetis Services LLC
    • IDvet
    • Thermo Fisher Scientific Inc.
    • Enfer Group
    • AsureQuality Australia Pty Ltd.
    • Bio-Rad Laboratories, Inc.
    • Bionote USA Inc.

Á¦13Àå ºÎ·Ï

ksm 24.12.30

Persistence Market Research has recently released a comprehensive report on the global Bovine Tuberculosis Diagnosis Market, providing an in-depth analysis of key market dynamics, including driving forces, emerging trends, opportunities, and challenges. This report offers a detailed understanding of the market landscape, helping stakeholders make well-informed decisions.

Key Insights:

  • Bovine Tuberculosis Diagnosis Market Size (2024E): US$ 768.6 Mn
  • Projected Market Value (2031F): US$ 1,053.2 Mn
  • Global Market Growth Rate (CAGR 2024 to 2031): 4.4%

Bovine Tuberculosis Diagnosis Market - Report Scope:

The Bovine Tuberculosis (TB) Diagnosis market refers to the technologies and methods used to detect and diagnose bovine tuberculosis in livestock, particularly cattle. This disease is a major concern for the agricultural sector, as it can affect livestock health and result in significant economic losses due to trade restrictions and veterinary treatment costs. The market is driven by increasing concerns over zoonotic diseases, the need for accurate and timely diagnosis, and the growing awareness of the economic impact of bovine TB outbreaks.

Market Growth Drivers:

Several factors are contributing to the growth of the global Bovine Tuberculosis Diagnosis market. These include the rising prevalence of bovine tuberculosis, increasing investments in veterinary healthcare, and the adoption of advanced diagnostic technologies such as PCR testing, immunodiagnostics, and imaging techniques. Furthermore, governments' initiatives to combat bovine tuberculosis through vaccination programs and stringent regulations are expected to support market growth. The increasing demand for high-quality dairy and meat products, along with the need for disease-free livestock, is also driving the market forward.

Market Restraints:

Despite the positive market outlook, the Bovine Tuberculosis Diagnosis market faces challenges such as high diagnostic costs and the complexity of TB testing in livestock. The lack of standardized diagnostic protocols in some regions, particularly in developing countries, may also impede market expansion. Furthermore, the slow adoption of new technologies in traditional farming systems and regulatory hurdles related to animal disease control may limit market growth.

Market Opportunities:

The Bovine Tuberculosis Diagnosis market presents significant opportunities driven by innovations in diagnostic technologies and the increasing adoption of rapid, cost-effective testing methods. The development of point-of-care diagnostic solutions and mobile diagnostic platforms is expected to enhance the accessibility and efficiency of bovine TB detection, especially in rural and remote areas. Additionally, growing awareness about the economic and public health risks associated with bovine tuberculosis is likely to result in increased funding and public-private partnerships to support research and development in this area.

Key Questions Answered in the Report:

  • What are the primary factors driving the growth of the global Bovine Tuberculosis Diagnosis market?
  • What diagnostic technologies and methods are leading the market in terms of adoption and revenue?
  • How are innovations in diagnostic tools and techniques influencing the bovine tuberculosis diagnosis industry?
  • Who are the leading players in the Bovine Tuberculosis Diagnosis market, and what strategies are they employing to maintain their market positions?
  • What are the emerging trends and future prospects in the global Bovine Tuberculosis Diagnosis market?

Competitive Intelligence and Business Strategy:

Leading companies in the global Bovine Tuberculosis Diagnosis market, such as IDEXX Laboratories, Thermo Fisher Scientific, and Zoetis, are focusing on expanding their product portfolios, enhancing the accuracy and speed of diagnostic tests, and increasing their geographic presence. These companies are investing in the development of advanced diagnostic platforms and collaborating with veterinary institutions and agricultural agencies to expand their customer base. Strategic partnerships and collaborations with research institutions, along with a focus on regulatory compliance and maintaining high standards of diagnostic quality, are key to sustaining a competitive edge in the market.

Key Companies Profiled:

  • IDEXX Laboratories, Inc.
  • PBD Biotech Ltd
  • Zoetis Services LLC
  • IDvet
  • Thermo Fisher Scientific Inc.
  • Enfer Group
  • AsureQuality Australia Pty Ltd.
  • Bio-Rad Laboratories, Inc.
  • Bionote USA Inc.

Bovine Tuberculosis Diagnosis Market Segmentation

By Test Type

  • Serological Tests
  • Molecular Diagnostic Tests
  • Traditional Tests

By Region

  • North America
  • Europe
  • East Asia
  • South Asia and Oceania
  • Latin America
  • Middle East and Africa

Table of Contents

1. Executive Summary

  • 1.1. Bovine Tuberculosis Diagnosis Market Snapshot, 2024 - 2031
  • 1.2. Market Opportunity Assessment, 2024 - 2031, US$ Mn
  • 1.3. Key Market Trends
  • 1.4. Future Market Projections
  • 1.5. Premium Market Insights
  • 1.6. Industry Developments and Key Market Events
  • 1.7. PMR Analysis and Recommendations

2. Market Overview

  • 2.1. Market Scope and Definition
  • 2.2. Market Dynamics
    • 2.2.1. Drivers
    • 2.2.2. Restraints
    • 2.2.3. Opportunity
    • 2.2.4. Challenges
    • 2.2.5. Key Trends
  • 2.3. Macro-Economic Factors
    • 2.3.1. Global Sectorial Outlook
    • 2.3.2. Global GDP Growth Outlook
    • 2.3.3. Global Healthcare Spending Outlook
  • 2.4. COVID-19 Impact Analysis
  • 2.5. Forecast Factors - Relevance and Impact

3. Value Added Insights

  • 3.1. Test Type Adoption Analysis
  • 3.2. Regulatory Landscape
  • 3.3. Value Chain Analysis
    • 3.3.1. List of Distribution Channel/Marketplaces
      • 3.3.1.1. Retail
      • 3.3.1.2. Audiology
      • 3.3.1.3. E-Commerce
    • 3.3.2. List of End User (Industry)
  • 3.4. Key Deals and Mergers
  • 3.5. PESTLE Analysis
  • 3.6. Porter's Five Force Analysis

4. Bovine Tuberculosis Diagnosis Market Outlook: Historical (2019 - 2023) and Forecast (2024 - 2031)

  • 4.1. Key Highlights
    • 4.1.1. Market Size (US$ Mn ) and Y-o-Y Growth
    • 4.1.2. Absolute $ Opportunity
  • 4.2. Market Size (US$ Mn ) Analysis and Forecast
    • 4.2.1. Historical Market Size (US$ Mn ) Analysis, 2019 - 2023
    • 4.2.2. Current Market Size (US$ Mn ) Analysis and Forecast, 2024 - 2031
  • 4.3. Bovine Tuberculosis Diagnosis Market Outlook: Test Type
    • 4.3.1. Introduction / Key Findings
    • 4.3.2. Historical Market Size (US$ Mn ) Analysis, By Test Type, 2019 - 2023
    • 4.3.3. Current Market Size (US$ Mn ) Analysis and Forecast, By Test Type, 2024 - 2031
      • 4.3.3.1. Serological Tests
      • 4.3.3.2. Molecular Diagnostic Tests
      • 4.3.3.3. Traditional Tests
    • 4.3.4. Market Attractiveness Analysis: Test Type

5. Bovine Tuberculosis Diagnosis Market Outlook: Region

  • 5.1. Key Highlights
  • 5.2. Historical Market Size (US$ Mn ) Analysis, By Region, 2019 - 2023
  • 5.3. Current Market Size (US$ Mn ) Analysis and Forecast, By Region, 2024 - 2031
    • 5.3.1. North America
    • 5.3.2. Europe
    • 5.3.3. East Asia
    • 5.3.4. South Asia and Oceania
    • 5.3.5. Latin America
    • 5.3.6. Middle East & Africa
  • 5.4. Market Attractiveness Analysis: Region

6. North America Bovine Tuberculosis Diagnosis Market Outlook: Historical (2019 - 2023) and Forecast (2024 - 2031)

  • 6.1. Key Highlights
  • 6.2. Historical Market Size (US$ Mn ) Analysis, By Market, 2019 - 2023
    • 6.2.1. By Country
    • 6.2.2. By Test Type
  • 6.3. Current Market Size (US$ Mn ) Analysis and Forecast, By Country, 2024 - 2031
    • 6.3.1. U.S.
    • 6.3.2. Canada
  • 6.4. Current Market Size (US$ Mn ) Analysis and Forecast, By Test Type, 2024 - 2031
    • 6.4.1. Serological Tests
    • 6.4.2. Molecular Diagnostic Tests
    • 6.4.3. Traditional Tests
  • 6.5. Market Attractiveness Analysis

7. Europe Bovine Tuberculosis Diagnosis Market Outlook: Historical (2019 - 2023) and Forecast (2024 - 2031)

  • 7.1. Key Highlights
  • 7.2. Historical Market Size (US$ Mn ) Analysis, By Market, 2019 - 2023
    • 7.2.1. By Country
    • 7.2.2. By Test Type
  • 7.3. Current Market Size (US$ Mn ) Analysis and Forecast, By Country, 2024 - 2031
    • 7.3.1. Germany
    • 7.3.2. France
    • 7.3.3. U.K.
    • 7.3.4. Italy
    • 7.3.5. Spain
    • 7.3.6. Russia
    • 7.3.7. Turkey
    • 7.3.8. Rest of Europe
  • 7.4. Current Market Size (US$ Mn ) Analysis and Forecast, By Test Type, 2024 - 2031
    • 7.4.1. Serological Tests
    • 7.4.2. Molecular Diagnostic Tests
    • 7.4.3. Traditional Tests
  • 7.5. Market Attractiveness Analysis

8. East Asia Bovine Tuberculosis Diagnosis Market Outlook: Historical (2019 - 2023) and Forecast (2024 - 2031)

  • 8.1. Key Highlights
  • 8.2. Historical Market Size (US$ Mn ) Analysis, By Market, 2019 - 2023
    • 8.2.1. By Country
    • 8.2.2. By Test Type
  • 8.3. Current Market Size (US$ Mn ) Analysis and Forecast, By Country, 2024 - 2031
    • 8.3.1. China
    • 8.3.2. Japan
    • 8.3.3. South Korea
  • 8.4. Current Market Size (US$ Mn ) Analysis and Forecast, By Test Type, 2024 - 2031
    • 8.4.1. Serological Tests
    • 8.4.2. Molecular Diagnostic Tests
    • 8.4.3. Traditional Tests
  • 8.5. Market Attractiveness Analysis

9. South Asia & Oceania Bovine Tuberculosis Diagnosis Market Outlook: Historical (2019 - 2023) and Forecast (2024 - 2031)

  • 9.1. Key Highlights
  • 9.2. Historical Market Size (US$ Mn ) Analysis, By Market, 2019 - 2023
    • 9.2.1. By Country
    • 9.2.2. By Test Type
  • 9.3. Current Market Size (US$ Mn ) Analysis and Forecast, By Country, 2024 - 2031
    • 9.3.1. India
    • 9.3.2. Southeast Asia
    • 9.3.3. ANZ
    • 9.3.4. Rest of South Asia & Oceania
  • 9.4. Current Market Size (US$ Mn ) Analysis and Forecast, By Test Type, 2024 - 2031
    • 9.4.1. Serological Tests
    • 9.4.2. Molecular Diagnostic Tests
    • 9.4.3. Traditional Tests
  • 9.5. Market Attractiveness Analysis

10. Latin America Bovine Tuberculosis Diagnosis Market Outlook: Historical (2019 - 2023) and Forecast (2024 - 2031)

  • 10.1. Key Highlights
  • 10.2. Historical Market Size (US$ Mn ) Analysis, By Market, 2019 - 2023
    • 10.2.1. By Country
    • 10.2.2. By Test Type
  • 10.3. Current Market Size (US$ Mn ) Analysis and Forecast, By Country, 2024 - 2031
    • 10.3.1. Brazil
    • 10.3.2. Mexico
    • 10.3.3. Rest of Latin America
  • 10.4. Current Market Size (US$ Mn ) Analysis and Forecast, By Test Type, 2024 - 2031
    • 10.4.1. Serological Tests
    • 10.4.2. Molecular Diagnostic Tests
    • 10.4.3. Traditional Tests
  • 10.5. Market Attractiveness Analysis

11. Middle East & Africa Bovine Tuberculosis Diagnosis Market Outlook: Historical (2019 - 2023) and Forecast (2024 - 2031)

  • 11.1. Key Highlights
  • 11.2. Historical Market Size (US$ Mn ) Analysis, By Market, 2019 - 2023
    • 11.2.1. By Country
    • 11.2.2. By Test Type
  • 11.3. Current Market Size (US$ Mn ) Analysis and Forecast, By Country, 2024 - 2031
    • 11.3.1. GCC Countries
    • 11.3.2. Egypt
    • 11.3.3. South Africa
    • 11.3.4. Northern Africa
    • 11.3.5. Rest of Middle East & Africa
  • 11.4. Current Market Size (US$ Mn ) Analysis and Forecast, By Test Type, 2024 - 2031
    • 11.4.1. Serological Tests
    • 11.4.2. Molecular Diagnostic Tests
    • 11.4.3. Traditional Tests
  • 11.5. Market Attractiveness Analysis

12. Competition Landscape

  • 12.1. Market Share Analysis, 2023
  • 12.2. Market Structure
    • 12.2.1. Competition Intensity Mapping By Market
    • 12.2.2. Competition Dashboard
  • 12.3. Company Profiles (Details - Overview, Financials, Strategy, Recent Developments)
    • 12.3.1. IDEXX Laboratories, Inc.
      • 12.3.1.1. Overview
      • 12.3.1.2. Segments and Test Types
      • 12.3.1.3. Key Financials
      • 12.3.1.4. Market Developments
      • 12.3.1.5. Market Strategy
    • 12.3.2. PBD Biotech Ltd
    • 12.3.3. Zoetis Services LLC
    • 12.3.4. IDvet
    • 12.3.5. Thermo Fisher Scientific Inc.
    • 12.3.6. Enfer Group
    • 12.3.7. AsureQuality Australia Pty Ltd.
    • 12.3.8. Bio-Rad Laboratories, Inc.
    • 12.3.9. Bionote USA Inc.

13. Appendix

  • 13.1. Research Methodology
  • 13.2. Research Assumptions
  • 13.3. Acronyms and Abbreviations
ºñ±³¸®½ºÆ®
0 °ÇÀÇ »óǰÀ» ¼±Åà Áß
»óǰ ºñ±³Çϱâ
Àüü»èÁ¦